Co-Authors
This is a "connection" page, showing publications co-authored by Laurence Jesel and Olivier Morel.
Connection Strength
5.723
-
Atrial arrhythmias in Takotsubo cardiomyopathy: incidence, predictive factors, and prognosis. Europace. 2019 Feb 01; 21(2):298-305.
Score: 0.807
-
Ventricular arrhythmias and sudden cardiac arrest in Takotsubo cardiomyopathy: Incidence, predictive factors, and clinical implications. Heart Rhythm. 2018 08; 15(8):1171-1178.
Score: 0.762
-
Microparticles in COVID-19 as a link between lung injury extension and thrombosis. ERJ Open Res. 2021 Apr; 7(2).
Score: 0.238
-
Acute Pulmonary Embolism in Patients with and without COVID-19. J Clin Med. 2021 May 11; 10(10).
Score: 0.236
-
D-Dimers Level as a Possible Marker of Extravascular Fibrinolysis in COVID-19 Patients. J Clin Med. 2020 Dec 24; 10(1).
Score: 0.230
-
Delayed pulmonary embolism after COVID-19 pneumonia: a case report. Eur Heart J Case Rep. 2020 Dec; 4(6):1-4.
Score: 0.229
-
Increased susceptibility to SARS-CoV-2 infection in patients with reduced left ventricular ejection fraction. ESC Heart Fail. 2021 02; 8(1):380-389.
Score: 0.228
-
Clinical features of patients with acute coronary syndrome during the COVID-19 pandemic. J Thromb Thrombolysis. 2021 Jul; 52(1):95-104.
Score: 0.228
-
Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic. J Thromb Thrombolysis. 2020 Nov; 50(4):799-808.
Score: 0.228
-
Staging Severity of COVID-19 according to Hemostatic Abnormalities (CAHA Score). Thromb Haemost. 2020 Dec; 120(12):1716-1719.
Score: 0.225
-
Venous thromboembolism in non-critically ill patients with COVID-19 infection. Thromb Res. 2020 09; 193:166-169.
Score: 0.223
-
COVID-19 Related Coagulopathy: A Distinct Entity? J Clin Med. 2020 May 31; 9(6).
Score: 0.221
-
Impact of COVID-19 on the Cardiovascular System: A Review. J Clin Med. 2020 May 09; 9(5).
Score: 0.220
-
Prognostic Value of Incomplete Revascularization after Percutaneous Coronary Intervention Following Acute Coronary Syndrome: Focus on CKD Patients. J Clin Med. 2019 Jun 06; 8(6).
Score: 0.207
-
Impact of Antithrombotic Regimen and Platelet Inhibition Extent on Leaflet Thrombosis Detected by Cardiac MDCT after Transcatheter Aortic Valve Replacement. J Clin Med. 2019 Apr 12; 8(4).
Score: 0.204
-
Assessment of Renal Dysfunction Improves the Simplified Pulmonary Embolism Severity Index (sPESI) for Risk Stratification in Patients with Acute Pulmonary Embolism. J Clin Med. 2019 Feb 01; 8(2).
Score: 0.202
-
Primary Hemostatic Disorders and Late Major Bleeding After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2018 10 30; 72(18):2139-2148.
Score: 0.198
-
CT-ADP Point-of-Care Assay Predicts 30-Day Paravalvular Aortic Regurgitation and Bleeding Events following Transcatheter Aortic Valve Replacement. Thromb Haemost. 2018 05; 118(5):893-905.
Score: 0.190
-
Management of a superinfected pyoderma gangrenosum after pacemaker implant. HeartRhythm Case Rep. 2019 Feb; 5(2):63-65.
Score: 0.190
-
Unexpected Problems of Antithrombotic Therapy with An Unusual Side Effect of Vitamin K Antagonists after Mitral Valve Replacement. J Heart Valve Dis. 2017 05; 26(3):309-313.
Score: 0.179
-
Early and Late Atrial Arrhythmias After Lung Transplantation - Incidence, Predictive Factors and Impact on Mortality. Circ J. 2017 Apr 25; 81(5):660-667.
Score: 0.176
-
Risk and Severity of COVID-19 and ABO Blood Group in Transcatheter Aortic Valve Patients. J Clin Med. 2020 Nov 22; 9(11).
Score: 0.057
-
Out-of-hospital cardiac arrest survivors sent for emergency angiography: a clinical score for predicting acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2017 Mar; 6(2):103-111.
Score: 0.044